FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity

M E Cardenas1, J Heitman

  • 1Department of Genetics, Durham, NC 27710, USA.

The EMBO Journal
|December 1, 1995
PubMed

Insights

Rapamycin, in complex with FKBP12, targets TOR2, a yeast vacuole-associated protein kinase. This interaction delocalizes TOR2, impacting cell cycle progression and vacuolar function, revealing a conserved signaling pathway.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Rapamycin inhibits cell cycle progression by targeting FKBP12-rapamycin complexes.
  • Genetic studies implicated TOR1 and TOR2 proteins as targets of FKBP12-rapamycin.
  • TOR2's role in cell cycle regulation and its localization were previously unclear.

Purpose of the Study:

  • To investigate the localization and function of the TOR2 protein in yeast.
  • To determine the effect of the FKBP12-rapamycin complex on TOR2 activity and localization.
  • To elucidate the role of TOR2 in cell cycle progression and vacuolar dynamics.

Main Methods:

  • Immunoprecipitation of TOR2 protein.
  • Assay of phosphatidylinositol-4 (PI-4) kinase activity associated with TOR2.
  • Analysis of FKBP12 binding to wild-type and mutant TOR2 in the presence of rapamycin.
  • Microscopy to assess TOR2 localization and vacuolar morphology.

Main Results:

  • TOR2 protein is membrane-associated and localized to the yeast vacuole surface.
  • Immunoprecipitated TOR2 exhibits PI-4 kinase activity.
  • Rapamycin stimulates FKBP12 binding to wild-type TOR2, causing its delocalization from the vacuole.
  • Delocalization, not inhibition of kinase activity, appears to be the key consequence of rapamycin binding.
  • TOR2 localization is crucial for its function and influences vacuolar morphology.

Conclusions:

  • TOR2 is an essential, conserved protein involved in cell cycle regulation.
  • Vacuolar localization of TOR2 is critical for its function in signal transduction.
  • Rapamycin-mediated delocalization of TOR2 from the vacuole disrupts its signaling pathway.
  • TOR2 plays a role in modulating vacuolar morphology and segregation.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...